Chromocell Therapeutics

Quarterly Financials

Values in thousands 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Revenue
$0
$0
$0
$0
Gross Profit
-466
EBITDA
-1,818
-1,655
-1,764
-1,933
EBIT
-1,825
-2,048
-1,767
-3,867
Net Income
-1,926
-1,694
-1,771
-2,562
Net Change In Cash
0
0
0
0
Free Cash Flow
-670
-177
-2,952
-1,991
Cash
513
1,254
2,405
3,770
Basic Shares
5,683
5,792
5,773
5,766

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2023-09-30 2022-12-31
Revenue
$0
$0
$0
$0
Gross Profit
-2,579
-391
EBITDA
-7,571
-6,862
-1,627
EBIT
-8,741
-13,724
-2,318
Net Income
-7,955
-7,380
-7,380
-2,458
Net Change In Cash
0
0
0
0
Free Cash Flow
-5,792
-981
-981
-1,567
Cash
513
96
96
55
Basic Shares
5,574
5,767
5,767
5,767

Earnings Calls

Quarter EPS
2024-09-30
-$0.29
2024-06-30
-$0.31
2024-03-31
-$0.44